Calamos Advisors
CMD

Calamos Advisors’s Cantel Medical Corporation CMD Stock Holding History

Calamos Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,400
Closed -$336K – 660
2015
Q4 		$336K Buy
+5,400
New +$329K ﹤0.01% 603

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Calamos Advisors's CMD Position: Q1 2016 in Review

Calamos Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2016, closing a stake of 5,400 shares — an estimated $336K sold.

Calamos Advisors first reported a position in CMD in Q4 2015 and held it in 1 quarter. The position peaked at $336K in Q4 2015. 218 funds tracked by Wall St. Rank hold CMD as of Q1 2016.

  • Calamos Advisors reported no remaining Cantel Medical Corporation position as of Q1 2016 after selling out during the quarter.
  • Calamos Advisors sold 5,400 Cantel Medical Corporation shares in Q1 2016, an estimated $336K.
  • Calamos Advisors first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 1 quarter.
  • Calamos Advisors's Cantel Medical Corporation position peaked at $336K in Q4 2015.
  • 218 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2016.

Based on Calamos Advisors's 13F filing for Q1 2016, filed 25 Apr 2016.